Apeiron’s Christian Angermayer: “AI, psychedelics and living for hundreds of years”
Description
The Sunday Times' tech correspondent Danny Fortson brings on Christian Angermayer, founder of Apeiron Investments, to talk about psychedelics in Oregon (4:15), the spiritual experience of a “trip” (11:30), progressing toward the first FDA approval (15:30), how this will be introduced into the market (21:10), why having a qualified guide/therapist is critical (25:30), gaining societal acceptance (30:20), why he funded the longevity XPrize (34:20), the new approach to ageing (41:00), why we are on the cusp of a breakthrough in life span (42:30), the Ozempic effect (49:00, thriving in a toxic society (56:20), and how AI dovetails with psychedelics and longevity (1:01:50).
Hosted on Acast. See acast.com/privacy for more information.
The Sunday Times’s tech correspondent Danny Fortson brings on Augustus Doricko to talk about becoming a Thiel fellow (3:15), looking for the proof of God (5:45), starting his first company (9:30) cloud seeding (11:30), the history of cloud seeding (13:30), on whether silver iodide is safe...
Published 04/26/24
The Sunday Times’ tech correspondent Danny Fortson brings on DoNotPay's Josh Browder to talk about how artificial intelligence is changing his business (4:20), paying a dividend (8:15), blowing up the myth that you have to lose money to get big (11:00), the coming AI crash (13:00), the path...
Published 04/19/24